Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study

Vijay R. Varma, Anup M. Oommen, Sudhir Varma, Ramon Casanova, Yang An, Ryan M. Andrews, Richard O’Brien, Olga Pletnikova, Juan C. Troncoso, Jon Toledo, Rebecca Baillie, Matthias Arnold, Gabi Kastenmueller, Kwangsik Nho, P. Murali Doraiswamy, Andrew J. Saykin, Rima Kaddurah-Daouk, Cristina Legido-Quigley, Madhav Thambisetty

Open source

DOI: 10.1371/journal.pmed.1002482
Published: 2018-01-25
Container: PLOS Medicine
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pmed.1002482,
  title = {Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study},
  author = {Vijay R. Varma and Anup M. Oommen and Sudhir Varma and Ramon Casanova and Yang An and Ryan M. Andrews and Richard O’Brien and Olga Pletnikova and Juan C. Troncoso and Jon Toledo and Rebecca Baillie and Matthias Arnold and Gabi Kastenmueller and Kwangsik Nho and P. Murali Doraiswamy and Andrew J. Saykin and Rima Kaddurah-Daouk and Cristina Legido-Quigley and Madhav Thambisetty},
  year = {2018},
  journal = {PLOS Medicine},
  doi = {10.1371/journal.pmed.1002482},
  url = {https://doi.org/10.1371/journal.pmed.1002482}
}

RIS

TY  - JOUR
TI  - Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
AU  - Vijay R. Varma
AU  - Anup M. Oommen
AU  - Sudhir Varma
AU  - Ramon Casanova
AU  - Yang An
AU  - Ryan M. Andrews
AU  - Richard O’Brien
AU  - Olga Pletnikova
AU  - Juan C. Troncoso
AU  - Jon Toledo
AU  - Rebecca Baillie
AU  - Matthias Arnold
AU  - Gabi Kastenmueller
AU  - Kwangsik Nho
AU  - P. Murali Doraiswamy
AU  - Andrew J. Saykin
AU  - Rima Kaddurah-Daouk
AU  - Cristina Legido-Quigley
AU  - Madhav Thambisetty
PY  - 2018
JO  - PLOS Medicine
DO  - 10.1371/journal.pmed.1002482
UR  - https://doi.org/10.1371/journal.pmed.1002482
ER  -

APA

Varma, V. R., Oommen, A. M., Varma, S., Casanova, R., An, Y., Andrews, R. M., O’Brien, R., Pletnikova, O., Troncoso, J. C., Toledo, J., Baillie, R., Arnold, M., Kastenmueller, G., Nho, K., Doraiswamy, P. M., Saykin, A. J., Kaddurah-Daouk, R., Legido-Quigley, C., & Thambisetty, M. (2018). Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002482

Source records

crossref · retrieved 2026-09-27T04:50:12.822Z